| 1276 |
당뇨병/비만/지질 |
|
Correction: Nonalcoholic fatty liver disease is a risk factor for large-for-gestational-age birthweight.
|
Hye Seung Jung |
PloS one |
2019/NA |
| 1275 |
당뇨병/비만/지질 |
|
Influence of Microbiota on Diabetic Foot Wound in Comparison with Adjacent Normal Skin Based on the Clinical Features.
|
Min Ji Jeon,Won Gu Kim,Tae Yong Kim,Won Bae Kim,Young Kee Shong |
BioMed research international |
2019/NA |
| 1274 |
당뇨병/비만/지질 |
|
Potential Diagnostic Hemorheological Indexes for Chronic Kidney Disease in Patients With Type 2 Diabetes.
|
Lee Jun Ho |
Frontiers in physiology |
2019/NA |
| 1273 |
당뇨병/비만/지질 |
|
Carvedilol improves glucose tolerance and insulin sensitivity in treatment of adrenergic overdrive in high fat diet-induced obesity in mice.
|
Kim Eui Hyun |
PloS one |
2019/NA |
| 1272 |
당뇨병/비만/지질 |
|
Gestational diabetes mellitus diagnosed at 24 to 28 weeks of gestation in older and obese Women: Is it too late?
|
Kim Yoo Lee |
PloS one |
2019/NA |
| 1271 |
당뇨병/비만/지질 |
|
Age-specific diabetes risk by the number of metabolic syndrome components: a Korean nationwide cohort study.
|
Hyuk Sang Kwon,Lee Min Kyung |
Diabetology & metabolic syndrome |
2019/NA |
| 1270 |
당뇨병/비만/지질 |
|
Dulaglutide as an Add-on to Insulin in Type 2 Diabetes; Clinical Efficacy and Parameters Affecting the Response in Real-World Practice.
|
Joong Yeol Park,Chang Hee Jung |
Diabetes, metabolic syndrome and obesity : targets and therapy |
2019/NA |
| 1269 |
당뇨병/비만/지질 |
|
Gut carbohydrate inhibits GIP secretion via a microbiota/SCFA/FFAR3 pathway., 239, 3
|
Lee Eun Young |
The Journal of endocrinology |
2018/12 |
HOME
LOGIN
JOIN
SEARCH
ENGLISH
